KIDNEY TRANSPLANT INFECTION
Clinical trials for KIDNEY TRANSPLANT INFECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT INFECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney transplant patients battling BK virus
Disease control Recruiting nowThis study tests two drug combinations to treat BK virus infection in kidney transplant recipients. BK virus can damage the new kidney, and standard care is to lower immune-suppressing drugs. The trial compares everolimus with reduced tacrolimus versus reduced tacrolimus plus lef…
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: NA • Sponsor: King Chulalongkorn Memorial Hospital • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
Immune-Guided strategy could reduce CMV infections in kidney transplants
Disease control Recruiting nowThis study compares two ways to prevent cytomegalovirus (CMV) infection in kidney transplant patients who already carry the virus. One approach gives antiviral drugs to everyone for three months, while the other uses immune system tests to decide who needs treatment. The goal is …
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 17, 2026 01:59 UTC
-
New trial aims to beat BK virus and save transplanted kidneys
Disease control Recruiting nowThis study tests whether reducing anti-rejection drugs, with or without an extra treatment called IVIG, can better control BK virus infections in kidney transplant patients. The virus can damage the new kidney, so the goal is to keep the kidney working well while avoiding rejecti…
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New approach could reduce harsh drug side effects for transplant patients fighting CMV
Disease control Recruiting nowThis study is testing whether a drug called letermovir can prevent cytomegalovirus (CMV) infections from coming back in high-risk kidney or kidney/pancreas transplant patients. Researchers want to see if switching to letermovir earlier than usual can reduce the time patients need…
Matched conditions: KIDNEY TRANSPLANT INFECTION
Phase: PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Apr 15, 2026 16:16 UTC